Amgen adds potential blockbuster drug with $3.7 bln ChemoCentryx deal
By Manas MishraAug 4 (Reuters) - Amgen Inc said on Thursday it would buy ChemoCentryx Inc for $3.7 billion as the U.S. drugmaker seeks to bolster its...
By Manas MishraAug 4 (Reuters) - Amgen Inc said on Thursday it would buy ChemoCentryx Inc for $3.7 billion as the U.S. drugmaker seeks to bolster its...